Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.

Saved in:
Bibliographic Details
Title: Measurement of circulating transcripts and gene cluster analysis predicts and defines therapeutic efficacy of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.
Authors: Bodei, L., Kidd, M.1, Modlin, I. imodlin@optonline.net, Severi, S.2, Drozdov, I.3, Nicolini, S.2, Kwekkeboom, D., Krenning, E., Baum, R., Paganelli, G.2
Source: European Journal of Nuclear Medicine & Molecular Imaging. May2016, Vol. 43 Issue 5, p839-851. 13p.
Database: Academic Search Ultimate
Description
ISSN:16197070
DOI:10.1007/s00259-015-3250-z